← All indications
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS.
Subtype terms (13)
More specific conditions that are subtypes of Antineoplastic Agents in the MeSH hierarchy.
- Angiogenesis Inhibitors
13 drugs (8 approved, 5 experimental)
- Antibiotics, Antineoplastic
- Anticarcinogenic Agents
- Antimetabolites, Antineoplastic
4 drugs (3 approved, 1 experimental)
- Antimitotic Agents
- Antineoplastic Agents, Alkylating
- Antineoplastic Agents, Hormonal
3 drugs approved
- Antineoplastic Agents, Immunological
5 drugs (3 approved, 2 experimental)
- Antineoplastic Agents, Phytogenic
- MTOR Inhibitors
3 drugs approved
- Myeloablative Agonists
7 drugs (5 approved, 2 experimental)
- Poly(ADP-ribose) Polymerase Inhibitors
6 drugs (4 approved, 2 experimental)
- Topoisomerase Inhibitors
Drugs by status
Phase 3 trials (9)
Phase 2 trials (27)
Phase 1 trials (5)
Other trials (4)